Search

everythinglearnresearchcommunity

for

Search:↓

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Lichen planopilaris can cause hair loss on limbs, not just the scalp.

More research is needed to understand and manage angioedema in pregnant women with lupus.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Latanoprost may cause scalp inflammation and delayed healing.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Facial lichen planopilaris may be triggered by shaving and mustard oil, and early detection is crucial for better treatment outcomes.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.